Protagenic Therapeutics I... (PTIX)
NASDAQ: PTIX
· Real-Time Price · USD
2.92
-0.15 (-4.89%)
At close: Aug 15, 2025, 3:59 PM
2.88
-1.41%
After-hours: Aug 15, 2025, 07:55 PM EDT
Protagenic Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -5.24M | -5.53M | -5.65M | -6.4M | -6.01M | -5M | -3.93M | -3.45M | -2.91M | -3.56M | -3.84M | -3.8M | -4.68M | -4.52M | -4.16M | -4.24M | -3.26M |
Depreciation & Amortization | 50.29K | 50.29K | 64.33K | 53.18K | 40.7K | 28.22K | 1.63K | 211.00 | 120.00 | 26.66K | 453.76K | 453.76K | 453.76K | 481.11K | 54.01K | 54.1K | 54.18K |
Stock-Based Compensation | 997.29K | 923.14K | 844.41K | 760.71K | 661.98K | 666.83K | 698.81K | 746.78K | 795.61K | 864.68K | 884.16K | 901.13K | 1.41M | 1.52M | 1.71M | 1.97M | 1.64M |
Other Working Capital | 665.48K | 556.35K | -42.04K | 222.11K | -239.13K | 20.13K | 343.96K | -62.99K | 436.77K | 962.39K | 556.28K | -111.34K | -87.22K | -559.29K | -435.16K | 94.29K | 203.51K |
Other Non-Cash Items | -220.75K | -33.95K | 781.4K | 874.67K | 951.38K | 793.91K | 90.48K | 123.27K | 131.35K | 133.6K | 150.93K | 214.36K | 404.75K | 427.14K | 429.02K | 373.6K | 181.52K |
Deferred Income Tax | n/a | n/a | -219.94K | -196.77K | -77.82K | -77.82K | 142.12K | 118.95K | n/a | -26.63K | -451.28K | -451.28K | -451.28K | -562.3K | -250.15K | -354.87K | -331.31K |
Change in Working Capital | 700.07K | 467.54K | -265.39K | 87.57K | -373.67K | -114.41K | 252.36K | -154.59K | 26.08K | 540.13K | 565.73K | -101.88K | 241.33K | -140.39K | -503.27K | 35.3K | 119.84K |
Operating Cash Flow | -3.63M | -4.22M | -4.54M | -5.01M | -4.99M | -3.7M | -2.74M | -2.62M | -1.94M | -1.99M | -2.22M | -2.76M | -2.62M | -2.8M | -2.71M | -2.16M | -1.59M |
Capital Expenditures | n/a | n/a | -93.97K | -149.78K | -149.78K | -149.78K | -57.61K | -1.8K | -1.8K | -1.8K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | -2.37K | 66.41K | 66.41K | 66.41K | 11.48K | -57.31K | -57.31K | -57.31K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | -297.12K | -3.05M | -3.06M | -3.06M | -2.76M | 56.26K | -34.12K | -34.12K | -34.12K | -10.5M | -20.79M | -20.79M | -20.79M | -10.4M | n/a | n/a |
Sales Maturities Of Investments | 1.55M | 3.05M | 8.17M | 8.88M | 8.89M | 7.69M | 2.66M | 2.46M | 1.56M | 1.63M | 2.03M | 1.57M | 859.2K | 488.43K | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 198.00 | 2.57K | -66.21K | -64.6K | -64.8K | -9.86K | 59.28K | 764.58K | 764.95K | 11.1M | 11.09M | 10.38M | 10.38M | -10.4K | n/a | n/a |
Investing Cash Flow | 1.6M | 2.8M | 5.08M | 5.67M | 5.68M | 4.78M | 2.66M | 2.43M | 1.52M | 1.6M | 1.92M | -8.83M | -9.54M | -9.91M | -9.17M | 1.22M | 1.22M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 100K | 100K | 527.5K | 1.1M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12.45M | 12.48M | 11.25M | 11.15M | -1.3M |
Financial Cash Flow | 2.07M | 1.96M | 361.49K | 44.53K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12.45M | 12.58M | 11.35M | 11.68M | -202.88K |
Net Cash Flow | 41.18K | 550.58K | 902.47K | 705.15K | 693.28K | 1.07M | -5K | -119.23K | -343.68K | -325.98K | -301.79K | -11.59M | 290.5K | -129.92K | -528.46K | 10.75M | -562.3K |
Free Cash Flow | -3.63M | -4.22M | -4.64M | -5.16M | -5.14M | -3.85M | -2.8M | -2.62M | -1.94M | -2M | -2.22M | -2.76M | -2.62M | -2.8M | -2.71M | -2.16M | -1.59M |